Issued Patents All Time
Showing 1–25 of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12194110 | PD-L1 binding polypeptides for imaging | Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, David Fabrizio +6 more | 2025-01-14 |
| 11858995 | Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia | Brian Elliott, Jenny Jianlin Chen, Tahamtan Ahmadi, Christopher Chiu, Esther BREIJ +1 more | 2024-01-02 |
| 11845805 | Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma | Brian Elliott, Tahamtan Ahmadi, Christopher Chiu, Esther BREIJ, Ida HIEMSTRA | 2023-12-19 |
| 11608383 | Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma | Brian Elliott, Tahamtan Ahmadi, Christopher Chiu, Esther BREIJ, Ida HIEMSTRA | 2023-03-21 |
| 11352440 | Antibodies against CD73 and uses thereof | Nils Lonberg, Alan J. Korman, Bryan C. BARNHART, Aaron P. YAMNIUK, Mohan Srinivasan +13 more | 2022-06-07 |
| 11344639 | PET imaging with PD-L1 binding polypeptides | Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, David Fabrizio +7 more | 2022-05-31 |
| 11173219 | PD-L1 binding polypeptides for imaging | Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, David Fabrizio +6 more | 2021-11-16 |
| 11103579 | Combination of DR5 agonist and anti-PD-1 antagonist and methods of use | Bryan C. BARNHART | 2021-08-31 |
| 10604575 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2020-03-31 |
| 10584170 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2020-03-10 |
| 10577423 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2020-03-03 |
| 10406251 | PD-L1 binding polypeptides for imaging | Paul E. Morin, David J. Donnelly, Dasa Lipovsek, Jochem Gokemeijer, David Fabrizio +6 more | 2019-09-10 |
| 10323093 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2019-06-18 |
| 10323092 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2019-06-18 |
| 10316090 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2019-06-11 |
| 10316091 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2019-06-11 |
| 10308714 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2019-06-04 |
| 10266594 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2019-04-23 |
| 10266596 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2019-04-23 |
| 10266595 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2019-04-23 |
| 10167343 | Antibodies against CD73 | Nils Lonberg, Alan J. Korman, Bryan C. BARNHART, Aaron P. YAMNIUK, Mohan Srinivasan +13 more | 2019-01-01 |
| 10138299 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2018-11-27 |
| 10100129 | Antibodies against CD73 and uses thereof | Nils Lonberg, Alan J. Korman, Bryan C. BARNHART, Aaron P. YAMNIUK, Mohan Srinivasan +13 more | 2018-10-16 |
| 10072082 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2018-09-11 |
| 9856320 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | John P. Cogswell, Stacie M. Goldberg, Ashok K. Gupta, Xi-Tao Wang, Jon M. Wigginton | 2018-01-02 |